|
Her1/EGFR and cross-talk
I'm sure I am oversimplifying this, but maybe someone can help me out with something that is bothering me.
Given the information we have about cross-talk through the HER family (Her1/EGFR, Her2, and Her3) - is there a reason that oncologists are not routinely testing Her2 positive patients for the other growth factors and treating accordingly (ie with Iressa or Lapitinib or another pan-Her drug)?
Thanks for any help.
Amy
|